A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly doses of palivizumab for RSV prevention protocol has been approved for high risk preterm infants since December 2010. This study aimed to determine the clinical effectiveness and safety of this novel p...

Full description

Bibliographic Details
Main Authors: Hsin Chi, Chyong-Hsin Hsu, Jui-Hsing Chang, Nan-Chang Chiu, Han-Yang Hung, Hsin-An Kao, Li-Chuan Weng, Fu-Yuan Huang, Yu-Ying Chiu, Luan-Yin Chang, Li-Min Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4074126?pdf=render

Similar Items

Similar Items